Stonegate Updates Coverage on EnSilica PLC (ENSI) Mid-Year Update 1H 2025
Dallas, Texas--(Newsfile Corp. - June 26, 2025) - EnSilica PLC (AIM: ENSI): Stonegate Capital Partners updates their coverage on EnSilica PLC (AIM: ENSI) during the mid-year of 1H25. Through the beginning of calendar 2025, EnSilica PLC continued to build on its strategic initiatives and market strengths, achieving significant milestones. The Company's strong position and intellectual property in automotive, industrial, healthcare, and satellite connectivity applications...
2025-06-26 9:22 AM EDT
Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) FY25 Q4
Dallas, Texas--(Newsfile Corp. - June 26, 2025) - Burcon Nutrascience Corporation (TSX: BU): Stonegate Capital Partners updates their coverage on Burcon Nutrascience Corporation (TSX: BU). Subsequent to the 2025 year end, Burcon made continued significant progress in its strategic initiatives. The Company successfully scaled up commercial production of its pea protein isolate, marking a pivotal milestone in its go-to-market strategy. This scale up was...
2025-06-26 9:16 AM EDT
Chemify Launches the World's First Chemputation Facility Revolutionizing Molecular Design and Manufacture
Glasgow, Scotland--(Newsfile Corp. - June 20, 2025) - Chemify, the deep-tech pioneer fusing chemistry, robotics, computation and AI to digitise molecule creation, today unveiled its first Chemifarm--a fully automated chemistry facility regarded as the world's most advanced laboratory for molecular design and synthesis. To view the full announcement, including downloadable images, bios, and more, click here....
2025-06-20 3:20 AM EDT
Stonegate Capital Partners Initiates Coverage on Cingulate Inc. (CING)
Dallas, Texas--(Newsfile Corp. - June 18, 2025) - Cingulate Inc. (NASDAQ: CING): Stonegate Capital Partners initiates their coverage on Cingulate Inc. (NASDAQ: CING). Cingulate reported 1Q25 results that highlight continued progress toward the commercial launch of its lead ADHD asset, CTx-1301. The Company remains focused on leveraging its proprietary Precision Timed Release (PTR) platform to address long-standing gaps in ADHD treatment. CTx- 1301 is...
2025-06-18 8:00 AM EDT
Stonegate Capital Partners Updates Coverage On Aemetis, Inc. (AMTX) Q1 2025
Dallas, Texas--(Newsfile Corp. - June 16, 2025) - Stonegate Capital Partners updates coverage on Aemetis, Inc. (Nasdaq: AMTX). In the first quarter of 2025, Aemetis reported total revenues of $42.9M, compared to $72.6M in the same period last year, with the year-over-year decline primarily driven by shifts in timing in receiving new government biodiesel contracts in India. Net loss for the quarter was $24.5M, relatively flat versus a net loss...
2025-06-16 4:31 PM EDT
Stonegate Updates Coverage on Hooker Furniture Corporation (HOFT) Q1 FY26
Dallas, Texas--(Newsfile Corp. - June 13, 2025) - Hooker Furniture Corporation (NASDAQ: HOFT): Stonegate Capital Partners updates their coverage on Hooker Furniture Corporation (NASDAQ: HOFT). HOFT reported revenue, operating income, and adj EPS of $85.3M, ($3.6)M, and ($0.29), respectively. This compares to our/consensus estimates of $92.6M/$88.9M, ($2.5)M/($2.5)M, and ($0.16)/($0.15). It is noted that revenues were slightly below consensus estimates and...
2025-06-13 10:57 AM EDT
Lifordi Immunotherapeutics Presents Preclinical Data on Glucocorticoid Antibody Drug Conjugate LFD-200 to Treat Autoimmune and Inflammatory Diseases at EULAR 2025
Burlington, Massachusetts--(Newsfile Corp. - June 11, 2025) - Lifordi Immunotherapeutics, Inc., a biotech company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, presented preclinical data on its lead program for LFD-200, an ADC delivering a potent glucocorticoid (GC) directly to immune cells. Results of multiple in vitro and in vivo studies in mice and in non-human primates (NHPs) demonstrated that...
2025-06-11 8:41 AM EDT
Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) Mid-Quarter Update FY25 Q4
Dallas, Texas--(Newsfile Corp. - June 10, 2025) - Burcon Nutrascience Corporation (TSX: BU): Stonegate Capital Partners updates their coverage on Burcon Nutrascience Corporation (TSX: BU) during the mid-quarter of 4Q25. Subsequent to the third quarter of 2025, Burcon made continued significant progress in its strategic initiatives. The Company successfully scaled up commercial production of its pea protein isolate, marking a pivotal milestone in its...
2025-06-10 9:48 AM EDT
Tevard Biosciences Names Dr. Elisabeth Gardiner Chief Scientific Officer to Lead Next Phase of tRNA-Based Therapies
Boston, Massachusetts--(Newsfile Corp. - June 10, 2025) - Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, today announced the appointment of Elisabeth Gardiner, Ph.D., as Chief Scientific Officer. With more than 25 years of leadership in drug discovery and development across the biotech and pharmaceutical sectors, Dr. Gardiner brings deep translational expertise that will accelerate Tevard's mission to develop...
2025-06-10 8:05 AM EDT
Phizzle to Launch Technical First for IoT Edge
San Francisco, California--(Newsfile Corp. - June 5, 2025) - Phizzle, Inc., will launch on June 10th a technical first for the IoT Edge: the industry's only purpose-built computer inside a gateway that is malware-hardened to format and normalize data from any device or machine in edge use cases, including pharma manufacturing, building automation and AI systems, among others. ...
2025-06-05 9:59 AM EDT
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 25
Dallas, Texas--(Newsfile Corp. - June 4, 2025) - Bio-Path Holdings, Inc. (OTCQB: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (OTCQB: BPTH) for Q1 2025. Bio-Path Holdings, Inc. (OTCQB: BPTH) is a clinical-stage biotechnology company based in Bellaire, Texas, pioneering RNA interference (RNAi) therapeutics through its proprietary DNAbilize® platform. This innovative technology employs neutral-charge, liposomal delivery of antisense oligonucleotides, enhancing drug stability and cellular uptake while minimizing toxicity. The...
2025-06-04 4:34 PM EDT
Q.ANT Debuts First Interactive Live Demonstration and New Benchmarks for Analog Photonic Computing at ISC 2025
Stuttgart, Germany--(Newsfile Corp. - June 4, 2025) - Q.ANT, today announced it will showcase live demonstrations of its photonic Native Processing Server (NPS) at ISC 2025, a leading global conference for high-performance computing (HPC). For the first time, attendees will be able to interact directly with functional photonic computing, witnessing how light can drive breakthroughs in energy and computational efficiency for AI, Physics Simulations, and other complex scientific workloads. ...
2025-06-04 4:30 AM EDT
VueReal and ACA TMetrix Partner to Expand Access to Breakthrough MicroLED Technology in Canada
Waterloo, Ontario--(Newsfile Corp. - May 29, 2025) - VueReal, the pioneer in MicroSolid Printing technology, today announced a strategic distribution partnership with ACA TMetrix, a premier Canadian distributor of high-tech test and measurement solutions. Through this collaboration, VueReal's Reference Design Kits (RDKs) and microLED evaluation platforms will be exclusively distributed by ACA TMetrix across Canada, empowering engineering teams to accelerate the adoption of next-generation...
2025-05-29 9:29 AM EDT
Stonegate Capital Partners Updates Coverage on Sky Harbour Group Corporation (SKYH) Q1 2025
Dallas, Texas--(Newsfile Corp. - May 29, 2025) - Sky Harbour Group Corp. (NYSE: SKYH): Stonegate Capital Partners updates their coverage on Sky Harbour Group Corp. (NYSE: SKYH). Sky Harbour continued to demonstrate strong momentum in 1Q25, driven by expanding its aviation infrastructure footprint and ramping operational capacity. During the quarter, the Company initiated operations at its Phoenix Deer Valley (DVT) campus and prepared for...
2025-05-29 9:23 AM EDT
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025
Dallas, Texas--(Newsfile Corp. - May 28, 2025) - Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners updates their coverage on Incannex Healthcare Inc. (NASDAQ: IXHL). During the third quarter of fiscal year 2025, IXHL reported R&D expenses of $2.74M, down from $3.28M in the same quarter of the previous year, reflecting cost containment measures. SG&A expenses were $2.27M, compared to $4.14M in the prior year, driven by strategic cost-saving initiatives....
2025-05-28 4:21 PM EDT
Argus Research Reaffirms $200M 2025 Revenue Forecast for Golden Matrix (GMGI)
Las Vegas, Nevada--(Newsfile Corp. - May 23, 2025) - Argus Research has issued an updated equity research report about Golden Matrix Group Inc. (NASDAQ: GMGI), reiterating its fair value estimate for GMGI shares. The report highlights significant upside potential relative to current trading levels and forecasts continued revenue growth and operational expansion across key global markets. To view the full announcement, including downloadable images, bios, and...
2025-05-23 10:54 AM EDT
Stonegate Capital Partners Updates Coverage on Aquafil Group (ECNL) Q1 2025
Dallas, Texas--(Newsfile Corp. - May 19, 2025) - Aquafil Group (MI: ECNL): Stonegate Capital Partners updates coverage on Aquafil Group (ECNL.MI). In 1Q25, ECNL observed improved profitability despite significant macro environment uncertainty. The Company experienced a market recovery for fibers in the US, with increased sales of ECONYL(R) products. On a consolidated basis, ECNL reported improved EBITDA margins compared to 1Q24 despite lower revenue....
2025-05-19 4:11 PM EDT
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q1 2025
Dallas, Texas--(Newsfile Corp. - May 19, 2025) - Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate Capital Partners updates their coverage on Alpha Cognition Inc. (NASDAQ: ACOG). Alpha Cognition began 2025 by launching ZUNVEYL(R) (benzgalantamine) to the U.S. long-term care (LTC) market on March 17, 2025, delivering on its commercialization timeline and budget. Early clinician and patient feedback has been positive, citing successful initial patient outcomes...
2025-05-19 10:25 AM EDT
Expanse (GMGI) Completes Multiple U.S. Integrations and Launches New Flagship Slot
Las Vegas, Nevada--(Newsfile Corp. - May 16, 2025) - Expanse Studios, the proprietary B2B game development unit of Golden Matrix Group Inc. (NASDAQ: GMGI), has successfully completed multiple new integrations across U.S.-focused social and sweepstakes casino platforms, alongside the official release of its newest flagship title, Gates of Olympia. To view the full announcement, including downloadable...
2025-05-16 3:29 PM EDT
Stonegate Capital Partners Updates Coverage on Surf Air Mobility Inc. (SRFM) 2025 Q1
Dallas, Texas--(Newsfile Corp. - May 15, 2025) - Surf Air Mobility Inc. (NYSE: SRFM): Stonegate Capital Partners updates their coverage on Surf Air Mobility Inc. (NYSE: SRFM). SRFM reported revenue, adj EBITDA, and adj EPS of $23.5M, ($14.4)M, and ($1.09), respectively. It is notable that the Company was well within both revenue and EBITDA guidance in the quarter, despite a short unscheduled downtime towards...
2025-05-15 9:25 AM EDT